Clinical Trial News and Research

RSS

Lack of Olig1 protein in lung tumors may increase risk of death

A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.

2 Apr 2007

ESMO explores collaboration to fight cancer on all fronts

Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.

2 Apr 2007

Treatment options for bipolar disorder

For depressed people with bipolar disorder who are taking a mood stabilizer, adding an antidepressant medication is no more effective than a placebo (sugar pill), according to results published online on March 28, 2007 in the New England Journal of Medicine.

1 Apr 2007

Successful tuberculosis treatment depends upon patient adherence

Nearly 2 million people die from tuberculosis each year, mainly in the poorest countries.

31 Mar 2007

MRI as a key component of the diagnostic workup for women with breast cancer

Up to 10 percent of women newly diagnosed with cancer in one breast develop cancer in the opposite breast.

31 Mar 2007

Bronchial thermoplasty study

A new report published in the prestigious New England Journal of Medicine (NEJM) shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.

30 Mar 2007

Study shows how antibiotic gentamicin affects cystic fibrosis patients with a stop mutation

Genetics tests could help provide cystic fibrosis (CF) patients with targeted treatment in future, pilot study authors suggest.

30 Mar 2007

Patient adherence an essential factor for successful tuberculosis treatment

Nearly 2 million people die from tuberculosis each year, mainly in the poorest countries. The pathogen, Koch's bacillus, can pass easily by aerial infection from one individual to another. The spread of the disease, favoured by the Aids epidemic and the appearance of multi-resistant strains, has led WHO to make tuberculosis control one of the world's main health priorities.

27 Mar 2007

Medications plus lifestyle changes work as well as angioplasty to reduce deaths in stable heart-disease patients

Coronary revascularization with stenting or balloon angioplasty combined with optimal medical therapy is no more effective in preventing a heart attack, other major cardiovascular events or death in patients with stable heart disease, than optimal medical therapy alone, results of a new study conducted in 50 hospitals in the U.S. and Canada has shown.

27 Mar 2007

Researchers look at whether creatine slows progression of Parkinson's disease

Researchers at the University of Rochester Medical Center are leading one of the largest clinical trials ever for Parkinson's disease.

25 Mar 2007

Progress towards better access to pandemic influenza vaccines for developing countries

The World Health Organization (WHO) is reporting progress towards ensuring access to pandemic influenza vaccines for developing countries in the event of a pandemic and other vaccine-related aspects of influenza pandemic preparedness.

25 Mar 2007

Stanford brain tumor vaccine to be tested nationally

When Susan Wright learned that she had a type of fatal, rapidly growing brain cancer at age 46, her doctors at the University of Florida told her she wouldn't live more than 18 months.

22 Mar 2007

Prescription drug safety legislation introduced in House

Democratic Reps. Henry Waxman (Calif.) and Edward Markey (Mass.) have introduced legislation (HR 1561) that they say would make greater strides toward ensuring the safety of prescription drugs than Senate legislation (S 484) introduced by Sens. Edward Kennedy (D-Mass.) and Mike Enzi (R-Wyo.), CQ HealthBeat reports.

22 Mar 2007

Researchers discover vitiligo gene

In a study appearing in the March 22 edition of The New England Journal of Medicine, researchers at St George's, University of London, the University of Colorado at Denver and Health Sciences Center (UCDHSC) and the Barbara Davis Center for Childhood Diabetes have discovered a connection between a gene and the chronic skin condition vitiligo, as well as a possible link to an array of other autoimmune diseases.

22 Mar 2007

CardioMEMS implants first wireless pressure sensor to monitor hypertension

CardioMEMS has announced that its wireless pressure sensor was successfully surgically implanted into the wrist of three severely hypertensive patients at Hospital DIPRECA in Santiago, Chile by cardio-thoracic surgeons, Miguel Luis Berr, MD and Michael Tuchek, DO.

22 Mar 2007

Curry related compound shows promise against Kennedy's disease

Scientists who focus on the molecular signaling that underlies prostate cancer have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene.

21 Mar 2007

Large trial demonstrates that the benefits of zinc supplementation for children

A clinical trial conducted by researchers at the Johns Hopkins Bloomberg School of Public concluded that daily zinc supplements reduced the risk of death among children aged 12 to 48 months by 18 percent.

19 Mar 2007

Obesity at the time of prostate-cancer diagnosis dramatically increases the risk of dying from the disease

Obese men who are diagnosed with prostate cancer have more than two-and-a-half times the risk of dying from the disease as compared to men of normal weight at the time of diagnosis, according to a study by researchers at Fred Hutchinson Cancer Research Center.

15 Mar 2007

Clinical trial of a medication to treat kleptomania

A small clinical trial of a medication to treat kleptomania has failed to find any conclusive benefit for patients with the impulsive stealing disorder, according to researchers at the Stanford University School of Medicine.

14 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007